Detalhe da pesquisa
1.
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Cytokine
; 129: 155031, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062145
2.
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells.
Parasitol Res
; 119(8): 2609-2622, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535734
3.
Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach.
Parasitology
; 146(11): 1467-1476, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31142384
4.
High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection.
Parasitology
; 146(3): 322-332, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30198459
5.
Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Exp Parasitol
; 199: 30-37, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30817917
6.
Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals.
Cell Immunol
; 334: 61-69, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30287082
7.
Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
Cell Immunol
; 331: 67-77, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29871740
8.
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.
Cell Immunol
; 323: 59-69, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29128045
9.
A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis.
Cytokine
; 111: 131-139, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142534
10.
Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis.
Parasitology
; 145(6): 740-751, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29113597
11.
Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis.
Exp Parasitol
; 186: 24-35, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448040
12.
Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.
Int J Mol Sci
; 19(1)2018 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301342
13.
Diagnosis of Canine Visceral Leishmaniasis by Flow Cytometry Serology using the rMELEISH Multiepitope Antigen Coupled in a Functional Bead.
Curr Pharm Biotechnol
; 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38409720
14.
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.
Vaccines (Basel)
; 8(2)2020 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32526867
15.
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.
NPJ Vaccines
; 5: 75, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32821440
16.
In silico Leishmania proteome mining applied to identify drug target potential to be used to treat against visceral and tegumentary leishmaniasis.
J Mol Graph Model
; 87: 89-97, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522092
17.
Immunodiagnosis of human and canine visceral leishmaniasis using recombinant Leishmania infantum Prohibitin protein and a synthetic peptide containing its conformational B-cell epitope.
J Immunol Methods
; 474: 112641, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31400411
18.
A Custom-Designed Recombinant Multiepitope Protein for Human Cytomegalovirus Diagnosis.
Recent Pat Biotechnol
; 13(4): 316-328, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31333134
19.
In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Acta Trop
; 191: 29-37, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586571
20.
In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection.
Biomed Pharmacother
; 109: 779-787, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30551531